Indeed, the overexpression of UBE2C was previously reported in hepatocellular carcinoma, thyroid, colon, breast, and lung cancer [8,9,10,11,12,13] and our data confirmed this upregulation (Figure 1). This evidence concerns the gene UBE2C and lung carcinoma.